In its suit, which was filed in the U.S. District Court for the District of Delaware last week, Nevro claims that Pompano Beach, Fla.-based StimWave infringed on patents related to Nevro’s Senza system and HF10 therapy.
Nevro is seeking preliminary and permanent injunctive relief against further infringement as well as damages and attorney’s fees, Redwood City, Calif.-based Nevro said.
“Stimwave has never practiced the methods or art stated in any Nevro patent. Receivers and signal delivery devices have been utilizing kHz frequency ranges for over 40 years. We plan to rigorously respond to this action and proceed with a motion to dismiss in the coming months as well as evaluate separate actions,” Stimwave CEO Laura Tyler Perryman said in a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.